Key Takeaways
- Profit doubled on flat revenue: PBT before exceptional items rose over 100% YoY in Q4 while revenue grew only 3%, driven by a deliberate shift in agrochemical product mix toward higher-margin products and input cost tailwinds.
- Agrochemicals carried the year: Of the ₹230 cr incremental EBIT from FY23 to FY24, nearly ₹205 cr came from the agrochemicals segment, powered by new insecticide launches and portfolio pruning of low-margin products.
- Upstream remains under pressure: The chemicals segment (petrochemicals, intermediates) fell 17% YoY in revenue and continues to face margin compression from Chinese dumping and commoditization, with no near-term recovery signaled.
- Cash pile is spoken for: Management pushed back on calls for a higher dividend, arguing that net working capital can swing ₹600-800 cr in a quarter and that cash is reserved for internal working capital and capex, not intercorporate lending.
- What to watch next quarter: Whether the monsoon is normal as projected, which would sustain agrochemical momentum; whether the dispersion debottlenecking investment gets a firm timeline; and any signal that upstream chemical margins are bottoming.
Agrochemicals: The Profit Engine
- Portfolio reshaped for margin: The team steered the existing product mix toward more profitable products, deliberately shifting out low-margin lines, while also taking price increases. This mix shift, not volume alone, drove the disproportionate profit contribution.
- Insecticide entry was incremental: BASF was historically not a big player in insecticides, which represent ~50% of the crop protection market. The launch of Eicon (new mode of action, sucking and piercing pests) complemented the existing blockbuster Exponus (chewing pests, thrips) with no cannibalization, opening an entirely new revenue pool.
- Channel discipline improved: Given erratic monsoons in recent years, the team placed product closer to application timing to avoid channel inventory buildup, reducing risk of returns or discounting.
- Monsoon outlook is the swing factor: Current projections for more normal monsoons are positive for the agricultural sector, but management declined to give forward-looking volume guidance, saying "we have to really see how the monsoon season really plays out."
Alex: "the team has done really a fantastic job to focus on on steering the product mix Beyond innovations that I just mentioned steering the existing product mix to more to a more profitable mix yeah even you know having to shift maybe some products out of the portfolio that had very low margin yeah so a very focused approach on profitability"
Upstream vs Downstream Divergence
- Downstream resilient on domestic consumption: Businesses tied to India's demographic dividend and domestic consumption (agro, dispersions, coatings, nutrition & care) performed well, with two-thirds of GDP being domestic consumption providing a structural floor.
- Materials: input cost relief, not pricing power: The materials segment improved on reduced input costs, with solid demand from automotive, furniture, construction and footwear. However, price levels have stabilized at a lower level and margin pressure continues from materials coming from China and the Middle East.
- Chemicals: deep margin pressure: Petrochemicals and intermediates revenue fell 17% (from ₹2,000 cr to ₹1,700 cr), still heavily under margin pressure due to commoditization and Chinese dumping. Management offered no timeline for recovery, noting China's ~5% GDP growth leaves open the question of whether restocking is temporary or sustained.
- Nutrition & Care: volatile within the year: Fundamentals are strong long-term, but the segment is exposed to import-dependent products (UV filters, optical brightening agents) and commodity price swings (vitamin A under pressure). The health and nutrition division specifically underperformed, with segment EBIT falling from ₹100 cr to ₹36 cr YoY.
Alex: "the down businesses have been performing quite nicely and we see that will continue with this momentum in India the Upstream businesses material segment we see an improvement recently but the pricing pressure is still on and especially still on the chemicals on the chemicals business it's difficult for me to make a prediction here"
Working Capital & Cash Management
- Net working capital held flat despite growth: Maintained at ~₹1,000 cr even as sales grew from ~₹9,500 cr to ~₹13,500-13,600 cr, reflecting tight discipline.
- Inventory financed by suppliers: Management explicitly stated that when inventory rises, accounts payable are managed to rise in tandem, so "the inventory is kind of financed by the suppliers not by BASF." Inventory days held at ~70 despite Red Sea disruptions.
- Receivables under control: Receivable days at 65 with only ~10% overdue, indicating strong collection discipline.
- Cash reserved for internal use: Responding to an analyst question on why dividends could not be higher, management argued net working capital can swing ₹600-800 cr in a quarter (e.g., June quarter last year hit ₹1,600 cr). Cash is kept for own working capital and capex needs, with ICD deployment described as incidental, not the purpose.
Narendranath J. Baliga: "when the inventory goes up we also ensure that the accounts payable also goes up so the inventory is kind of financed by the suppliers not by BASF always"
Capacity Expansion & Operational Milestones
- Dispersion line at capacity, debottlenecking next: The second line at Dahej (started mid-2022) is already full, enabling market share gains in northern and western India. The team is now considering debottlenecking that line, with a decision possible next year.
- E-coat capacity expanded: The e-coat manufacturing facility at Mangalore (base layer for corrosion protection on cars) was significantly expanded, supporting OEM customers Maruti Suzuki, Tata, and Mahindra.
- Polyurethane Technical Development Center ready: Construction completed in Navi Mumbai, with inauguration scheduled for the following week. Primarily aimed at Indian customers.
- Sustainability infrastructure built: Received REDcert2 certification for low product carbon footprint water-based dispersions at both Dahej and Mangalore, and signed a PPA to move Mangalore from 60% to 90% green electricity. Management noted low-PCF dispersions are future-ready "as long as there is a willingness to pay obviously by our customers."
- Overall capacity utilization: Management declined to disclose site-level or asset-level utilization but gave an overall figure of 80-85%.
Alexander Gerding: "that's also a testament that you know we made the right investment and it enabled us and the team actually to gain market share especially northern part of India, in western part of India"
Key Ratios & Financial Health
| Metric | Value | Context |
|---|---|---|
| ROCE | 26% | One of the best in recent years |
| RONA (operational assets only) | 29% | Reflects asset efficiency |
| EPS | ₹130 | Second best ever; FY22 ₹137 was best; FY21 ~₹130 but included construction chemical business sale |
| Cash flow from operations | ₹800 cr | vs ₹500 cr last year |
| Operating expenses | 7.8% of revenue | Slightly lower YoY |
| Receivable days | 65 days | ~10% overdue |
| Inventory days | ~70 days | Managed despite Red Sea disruptions |
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Dispersion debottlenecking | Debottlenecking of Dahej second line being considered | Decision possible next year |
| Kids lab CSR target | Expand from 1,900 kids to more than 3,000 kids | By end of calendar year |
| Green electricity at Mangalore | Move from 60% to 90% green electricity via signed PPA | No date given |
| Low-PCF dispersions commercialization | Produce low carbon footprint dispersions at Dahej and Mangalore | Conditional on customer willingness to pay |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Revenue | ₹3,300 cr, stabilized around this level per quarter |
| Full-year revenue | ₹13,768 cr, +1% YoY |
| PBT before exceptional items | ₹219 cr, +100% QoQ; third best quarter ever |
| Full-year PBT before exceptional items | +44% YoY |
| EPS | ₹130, second best ever; FY23 was ₹90, FY22 was ₹137 |
| ROCE | 26%, one of the best in recent years |
| RONA | 29%, excluding cash surplus and interest earned |
| Operating expenses | 7.8% of revenue, slightly lower than last year |
| Cash flow from operations | ₹800 cr, vs ₹500 cr last year |
| Net working capital | ~₹1,000 cr, maintained despite sales growth from ~₹9,500 cr to ~₹13,600 cr |
| Inventory days | ~70 days |
| Receivable days | 65 days, with ~10% overdue |
| Capacity utilization | 80% to 85% across plants |
| Capex | ~₹100 cr, mostly maintenance capex, no capacity expansion |
| Dividend | ₹15 per share, 150% of face value, recommended by board |